![[LSUK] Life-Sciences-UK.com - The UK Life Sciences Web Portal](/images/basics/lsuk-life-sciences-uk-portal-logo.svg){kind=logo}
Advertisement
Persons > All
Please find below persons from Ireland & the United Kingdom (GB) or related to organisations from these countries.Total search results: 4952 | Ordered by Person (ascending)
1 2 3 ... 41 42 43 ... 48 49 50 
  Person |
 Position |
Organisation (Group) |
Region |
|---|---|---|---|
| Sinclair, Andrew (Abingworth 202305) | n. a. | Carlyle (Group) | Greater London (region) |
| Sinclair, Mike (Halsin Partners 201110 Partner + Co-founder before Burns McClellan) | Public Relations Manager / Investor Relations Manager | Halsin Partners Ltd. | Greater London (region) |
| Sinemus, Kristina (Genius GmbH 201212 Managing Director + Prof at Quadriga Hochschule Berlin) | Managing Director | ECCO (Group) | Hessen (Hesse) (federal state) |
| Singh, Deepak (CN Innovations 202303– VP of Sales + Marketing at CN Bio before Horizon Discovery + PacBio + Affymetrix) | Sales Manager / Marketing Manager | CN Innovations (Group) | East of England (region) |
| Singh, Pawanbir (Trajan Scientific 201611 Pathology Market Manager) | Sales Manager / Marketing Manager | Trajan (Group) | North West England (region) |
| Singla Buxarrais, Guillem (Neurofenix 202003 CEO + Co-Founder) | Chief Executive Officer (CEO) | ||
| Sinha, Nihal (F-Prime Capital 202104 Principal) | Principal (venture capital) | F-Prime Capital Partners (F-Prime Biosciences) | Massachusetts (federal state) |
| Sinnamon, Julie (Ireland (govt) 202006 CEO of Enterprise Ireland) | Chief Executive Officer (CEO) | Ireland (govt) | Ireland (cl4) |
| Sirec, Teja (Refeyn 202309 Marketing Director) | Sales Manager / Marketing Manager | Refeyn (Group) | South East England (region) |
| Sirinakis, Kyp (Epidarex Capital 201701 Managing Partner before Rock Spring Ventures) | Managing Partner (investment firm) | Epidarex Capital (Group) | Scotland |
| Sixt, Bernhard (Edinburgh Molecular Imaging 201811– CEO before ImmunID + Agendia + Amersham + Nycomed) | Chief Executive Officer (CEO) | Edinburgh Molecular Imaging Ltd. (EM Imaging, EMI) | Scotland |
| Skaletsky, Mark (Trine Pharmaceuticals 200511 CEO + Domantis non-executive Board Chairman) | Chief Executive Officer (CEO) | Trine Pharmaceuticals Inc. | United States (USA)_o |
| Skentelbery, Claire (EuropaBio 202011– Director General before nia + CEBR + EBF) | Cluster Manager | EuropaBio aisbl – the European Association of Bioindustries | Brussels (region) |
| Skillington, Jeremy (Inflazome 201811 VP Business Development) | Business Development Manager / Strategy Manager | Roche (Group) | Ireland (cl4) |
| Skipp, Paul (Univ Southampton 201606 Director of Proteomics Research Centre) | Researcher (university / research institute) | University of Southampton | South East England (region) |
| Skovronsky, Daniel (Eli Lilly 201806 President of Lilly Research Labs) | n. a. | Eli Lilly (Group) | Indiana (federal state) |
| Skulme, Kristine (MolPort 201909 Marketing Manager) | Sales Manager / Marketing Manager | MolPort (Group) | Latvia_o |
| Slade, Andrew (Menarini 201303 President of Menarini Biologics) | President/Director/Head Business Group/Unit/Division | Menarini (Group) | Toscana (Tuscany) |
| Slade, Susan (Univ Warwick 20510 Dept Biological Sciences Head Mass Spec Facility) | Head Mass Spectrometry / NMR Laboratory (university / research institute) | University of Warwick | West Midlands (region) |
| Slagel, Dean (Esperante Ventures 201104 Managing Director) | Managing Director | Esperante (Group) | South East England (region) |
| Slaoui, Moncef (GSK –201707 Chairman Vaccines TO RETIRE 6/17) | President/Director/Head Business Group/Unit/Division | GSK (Group) | United Kingdom (state/region unspecified) |
| Slater, Martin (Cresset 201109– Director of Consulting before BioFocus since 1997) | management (personnel) | Cresset BioMolecular Discovery Ltd. | East of England (region) |
| Sleep, Nicholas (Procognia 200505) | n. a. | Procognia (Group) | South East England (region) |
| Slinger-Brennan, Jane (Proton Partner International 201907 Marketing + Communications Officer at Rutherford Diagnostics) | Sales Manager / Marketing Manager | Proton Partners International (PPI) (Group) | North West England (region) |
| Slingsby, Jason (LifeArc 202305– CBO before Oxford Biomedica + Miti Biosystems + ProtAffin) | Business Development Manager / Strategy Manager | LifeArc (GB) | Greater London (region) |
| Slootweg, Sander (Forbion Capital Partners 20111 Managing Partner before ABN AMRO Capital) | Managing Partner (investment firm) | Forbion (Group) | North Holland (province, NL) |
| Slupsky, Joseph (Univ Liverpoold 201705 Academic Lead of Cell Sorting + Mass Cytometry Facility) | Head Mass Spectrometry / NMR Laboratory (university / research institute) | University of Liverpool | North West England (region) |
| Small, Philip William (AMRI 200806– Managing Director Europe before Tripos) | Managing Director | Curia (Group) | New York (federal state) |
| Smart, Sam (Eyebiotech 202202 VP of Finance before Artios Pharma) | Chief Financial Officer (CFO) | Eyebiotech Ltd. (EyeBio) | Greater London (region) |
| Smirnyagina, Katya (Oxford Science Enterprises 202302 Senior Partner Life Sciences | Partner (venture partner) | Oxford Science Enterprises (Group) | South East England (region) |
| Smit, Jane (Oxford Investment Consultants 202102) | venture capital | Oxford Investment Consultants | South East England (region) |
| Smith Baxter, Gordon (BioWisdom 200604 CEO) | Chief Executive Officer (CEO) | Instem (Group) | East of England (region) |
| Smith, Adrian (Sysmex 202204– CEO of Oxford Gene Technology before Hologic UK/IE + Qiagen + Roche) | Chief Executive Officer (CEO) | Sysmex (Group) | South East England (region) |
| Smith, Andrew (Santhera 202004– CFO before Allecra Therapeutics + Sucampo Pharmaceuticals) | Chief Financial Officer (CFO) | Santhera (Group) | Northwestern Switzerland (region) |
| Smith, Austin (Univ Cambridge 201203 Prof + Director of Wellcome Trust Centre for Stem Cell Research) | Professor | University of Cambridge | East of England (region) |
| Smith, Brian (Waters 200901 VP Mass Spectrometry Operations) | Business Development Manager / Strategy Manager | Waters (Group) | Massachusetts (federal state) |
| Smith, Colin (Univ Surrey 200810 Prof) | Professor | University of Surrey | South East England (region) |
| Smith, Craig (Oxxon 200703 Chairman) | n. a. | Oxxon (Group) | South East England (region) |
| Smith, Daniel (Cobra Biologics 201509 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Charles River (Group) | West Midlands (region) |
| Smith, David (AstraZeneca 200709–201506 Executive VP of Operations RETIRED 6/15 before Estée Lauder before Timberland) | Chief Operating Officer (COO) | AstraZeneca (Group) | East of England (region) |
| Smith, David R. (Galapagos 201308– CFO/CEO services division before Cambridge Univ Hospitals + Galapagos + AstraZeneca) | Chief Financial Officer (CFO) | Galapagos (Group) | Flanders (Flemish region) |
| Smith, Gareth (ImaginAb 202105– General Manager Europe before Theragnostics) | General Manager (management) | ImaginAb (Group) | South East England (region) |
| Smith, Geoff (Cambridge Epigenetix 201603– CEO before Illumina) | Chief Executive Officer (CEO) | Cambridge Epigenetix Ltd. (CEGX) | East of England (region) |
| Smith, Georgia (United Kingdom (govt) 202210 Communications Manager at Medicines Discovery Catapult) | Public Relations Manager / Investor Relations Manager | United Kingdom (GB) (govt) | North West England (region) |
| Smith, Greg (IP Group 2022 CEO before CFO) | Chief Executive Officer (CEO) | IP Group (Group) | Greater London (region) |
| Smith, James A.D. (Genelabs 200708 President + CEO) | Chief Executive Officer (CEO) | GSK (Group) | California (federal state) |
| Smith, John (Peak Scientific 201304 Head of Gas) | n. a. | Peak Scientific (Group) | Scotland |
| Smith, Julian (PolyTherics 201309– CFO before Imperial Innovations + RadioScape) | Chief Financial Officer (CFO) | Abzena (Group) | Greater London (region) |
| Smith, Lisa (Univ Leicester 201211 Lecturer Dept of Criminology) | Researcher (university / research institute) | University of Leicester | East Midlands (region) |
| Smith, Mark (Finch Therapeutics 201601– CEO + OpenBiome 201201 Co-Founder) | Chief Executive Officer (CEO) | Finch Therapeutics (Group) | Massachusetts (federal state) |
| Smith, Mike (Zenith Technologies 201608 US Sales Manager) | Sales Manager / Marketing Manager | Zenith Technologies (Group) | Pennsylvania (federal state) |
| Smith, Owen (4BIO Ventures 202311 Partner) | Partner (venture partner) | 4BIO Ventures (4BIO Capital) (Group) | Greater London (region) |
| Smith, Paul (BioCity 201707– CEO of BioAscent Discovery before CXR Biosciences CEO) | Chief Executive Officer (CEO) | Pioneer Group, The (WAPG) (Group) | Scotland |
| Smith, Scott (Celgene 201710 COO) | Chief Operating Officer (COO) | Bristol Myers Squibb (BMS) (Group) | New Jersey (federal state) |
| Smith, Simon (Genetix 200809 Director Commercial Operations, Europe) | n. a. | Danaher (Group) | South East England (region) |
| Smith, Tony (Solexa 200604 VP + CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Illumina (Group) | East of England (region) |
| Smith-Farrell, Joanne (Be Biopharma 202103– CEO before Bluebird Bio + Merck (US) + Pfizer + Boston Consulting) | Chief Executive Officer (CEO) | Be Biopharma Inc. | Massachusetts (federal state) |
| Smoller, David A. (Dave) (Cultivation Capital 202010 General Partner before Horizon Discovery + Sage Labs + Sigma) | General Partner (venture partner) | Cultivation Capital (US Partnership) | Missouri (federal state) |
| Snowden, Mike (AstraZeneca 201304 Head of Discovery Sciences) | Research & Development Manager | AstraZeneca (Group) | East of England (region) |
| Soares, Rui (Paralab 201805 CEO) | General Manager (management) | Paralab (PT) | Portugal_o |
| Socha, Pierre R. (Amadeus Capital Partners 201907) | n. a. | Amadeus Capital (Group) | Greater London (region) |
| Soden, Christine (Acacia Pharma 201507– CFO joined 201502 before Celltech-Chiroscience + BTG + Optos + Medeva + Oxagen) | n. a. | Acacia Pharma (Group) | East of England (region) |
| Soenksen, Dirk G. (Aperio 201105 CEO) | Chief Executive Officer (CEO) | Danaher (Group) | California (federal state) |
| Soland, Daniel (Dan) (Uniqure 201512–201609 CEO before ViroPharma + Chiron Vaccines + Epigenesis RESIGNED 9/16) | Chief Executive Officer (CEO) | Uniqure (Group) | North Holland (province, NL) |
| Solari, Richard (InforSense 200611– before Oracle) | n. a. | Danaher (Group) | Greater London (region) |
| Solari, Roberto (Myricx Pharma 202011 CEO + Co-Founder + Visiting Prof at Imperial College London before GSK) | Chief Executive Officer (CEO) | Myricx Pharma Ltd. | East of England (region) |
| Soldan, Andrew (VLA UK 200911 Commercial Programme Manager) | n. a. | United Kingdom (GB) (govt) | United Kingdom (state/region unspecified) |
| Solomon, David Horn (Mithra Pharmaceuticals 202304– before Pharnext+ Silence Tx + Zealand Pharma + Bionor Pharma) | Chief Executive Officer (CEO) | Mithra Pharmaceuticals (Group) | Wallonia (region) |
| Somers, Deirdre (Irish Stock Exchange 201711 CEO) | Chief Executive Officer (CEO) | Euronext (Group) | Ireland (cl4) |
| Sommerfeld, Franziska (LGC 201009 LGC Genomics GmbH) | Public Relations Manager / Investor Relations Manager | LGC (Group) | Berlin (federal state) |
| Sommerford, Nathan (Zetta Genomics 202307– Chief Revenue Officer formerlay at Iqvia + Roche Diagnostics) | Sales Manager / Marketing Manager | Zetta Genomics (Group) | East of England (region) |
| Sommerville, Ross (OBN 201506– Interim CEO) | Chief Executive Officer (CEO) | OBN (UK) Ltd. | South East England (region) |
| Soni, Bobby (BioInnovation Institute 202012 CBO) | Chief Business Officer (CBO) | BioInnovation Institute (BII Foundation) | Hovedstaden |
| Soo, Whaijen (Shire 200711– Senior VP Research + Development before Biogen Idec) | Research & Development Manager | Takeda (Group) | Ireland (cl4) |
| Sore, Hannah (PharmEnable 202006 CEO + Co-Founder) | Chief Executive Officer (CEO) | PharmEnable Ltd. | East of England (region) |
| Soria, Jean-Charles (AstraZeneca 201903 SVP RnD Oncology) | Research & Development Manager | AstraZeneca (Group) | East of England (region) |
| Soriot, Pascal (AstraZeneca 201210– CEO before Roche COO Pharma Div before Genentech CEO) | Chief Executive Officer (CEO) | AstraZeneca (Group) | East of England (region) |
| Sottil (before Filipowicz), Aneta (Andrea Partners 201804– before EdRIP before Norgine 2013 before Rothschild) | Investment Manager | Andera Partners (FR) | Île-de-France (region) |
| Souêtre, Eric (Careventures 201011– Managing Partner + Labco 200904 CEO + Founder) | Chief Executive Officer (CEO) | Labco (Group) | France (region/state unspecified) |
| Southan, Andrew (Metrion Biosciences 201904– promoted to CEO joined 201610 before CeNeS + Ionix + BioFocus) | Chief Executive Officer (CEO) | Metrion Biosciences Ltd. | East of England (region) |
| Southern, Edwin | n. a. | Sysmex (Group) | South East England (region) |
| Spaggiari, Stefano (Expert System 201505 CEO) | Chief Executive Officer (CEO) | Expert System (Group) | Illinois (federal state) |
| Spagnol, Michel (Novasep 201306– CEO before Shasun + Rhodia) | Chief Executive Officer (CEO) | Novasep (Group) | Grand Est (Great East) (region) |
| Spears, John (Intradigm 200307 CEO) | Chief Executive Officer (CEO) | Silence Therapeutics (Group) | California (federal state) |
| Speciale, Daniel J. (Mallinckrodt 201907 VPA VP Investor Relations + IRO) | Public Relations Manager / Investor Relations Manager | Mallinckrodt (Group) | Ireland (cl4) |
| Spector, Tim (Univ London 201411 Professor of Genetic Epidemiology at King’s College London) | Professor | University of London | Greater London (region) |
| Speedie, Patrick (In-Part 202202 Co-CEO + Co-Founder) | Chief Executive Officer (CEO) | Inpart (Group) | Yorkshire and the Humber (region) |
| Spezzi, Andrea (Orchard Therapeutics 201903 CMO) | Chief Medical Officer (CMO) | Orchard Therapeutics (Group) | Greater London (region) |
| Spitz, Urs (Biosynth 201905 CEO) | Chief Executive Officer (CEO) | Biosynth (since 9/22) (Group) | Switzerland_other |
| Spooner, William H. (Will) (Zetta Genomics 202005– CEO + Co-Founder formerly Eagle Genomics) | Chief Executive Officer (CEO) | Zetta Genomics (Group) | East of England (region) |
| Spori, Bodo (Domainex 201803– Head BusDev Europe before Cyprotex + Scottish Biomedical Ltd) | Business Development Manager / Strategy Manager | Domainex Ltd. | East of England (region) |
| Sprance, Jennifer (Jen) (ABI Marketing Public Relations 201107 Global Director Life Sciences ABI Europe) | President/Director/Head Business Group/Unit/Division | ABI Inc. (Marketing Public Relations) | Greater London (region) |
| Spraul, Manfred (Bruker 201307 Director Apllied NMR Business Development) | Business Development Manager / Strategy Manager | Bruker (Group) | Massachusetts (federal state) |
| Sprawson, Rob (Cambridge Innovation Capital 201608 CFO) | Chief Financial Officer (CFO) | Cambridge Innovation Capital (Group) | East of England (region) |
| Sprigings, William (BioPark Hertfordshire 201106 Marketing Director) | Sales Manager / Marketing Manager | BioPark Hertfordshire | East of England (region) |
| Sproll, Marlies (MorphoSys 201711– Special Adviser to CEO before 200510–201710 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | MorphoSys (Group) | Bayern (federal state) |
| Spyrou, Maria (Zyme Communications 202305) | Public Relations Manager / Investor Relations Manager | Zyme Communications Ltd. | East of England (region) |
| Srinivasan, Kumar (AstraZeneca 201602 VP SP&A before Probiodrug + Wyeth Pharma + Torrey Pines) | Business Development Manager / Strategy Manager | AstraZeneca (Group) | |
| Staatz-Granzer, Irina (Staatz Business Development & Strategy 2006– + U3 Pharma 200804 CEO) | consulting (economic) | Staatz Business Development & Strategy – Dr. Irina Staatz-Granzer | Bayern (federal state) |
| Stabel Olsen, Siri (Skannex 201710 CEO) | Chief Executive Officer (CEO) | Skannex (Group) | Østlandet (Eastern Norway) (region) |
1 2 3 ... 41 42 43 ... 48 49 50
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
